The U.S. Food and Drug Administration (FDA) has approved bivalent formulations of the Moderna and Pfizer-BioNTech COVID-19 vaccines as a single booster dose. See the complete news release for more details on who is eligible to receive the single booster dose and when. The release also details specifics about:
- The mRNA components of bivalent COVID-19 vaccines.
- The omicron component in COVID-19 booster vaccines.
- How the FDA made its decision.
- Increased protection against the currently circulating omicron variant.
